JVA Q4 2019 Earnings EPS Misses Estimates Significantly Stock Rises Modestly Dianthus Therapeutics Q1 2026 Earnings EPS Beat Amid PreRevenue Stage SLM Q1 2026 Earnings EPS Surges Past Estimates Stock Gains FWONA Q4 2025 Earnings Modest EPS Miss Amid Steady Operational Progress CDP Q1 2026 Earnings EPS Slightly Above Estimates Amid Defense Portfolio Stability Oscar Health Inc OSCR Q1 2026 Earnings Massive EPS Beat Signals Strong Underwriting